Chemomab Therapeutics's total assets for Q4 2025 were $13.81M, an increase of 11.67% from the previous quarter. CMMB total liabilities were $1.48M for the fiscal quarter, a 29.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.